TIWARI, RAHUL
 Distribuzione geografica
Continente #
NA - Nord America 132
EU - Europa 76
AS - Asia 65
SA - Sud America 17
AF - Africa 3
Totale 293
Nazione #
US - Stati Uniti d'America 129
RU - Federazione Russa 31
IT - Italia 20
SG - Singapore 19
HK - Hong Kong 15
BR - Brasile 11
CN - Cina 8
VN - Vietnam 8
IE - Irlanda 7
FI - Finlandia 6
AR - Argentina 4
ID - Indonesia 4
KR - Corea 4
GB - Regno Unito 3
SE - Svezia 3
CA - Canada 2
CH - Svizzera 2
CI - Costa d'Avorio 2
DE - Germania 2
EC - Ecuador 2
FR - Francia 2
JO - Giordania 2
BD - Bangladesh 1
IN - India 1
MA - Marocco 1
MX - Messico 1
MY - Malesia 1
PK - Pakistan 1
SY - Repubblica araba siriana 1
Totale 293
Città #
Santa Clara 57
Ashburn 19
Singapore 15
Hong Kong 13
Milan 8
Dublin 7
Chandler 6
Altamura 4
Helsinki 4
Lawrence 4
Seoul 4
Beijing 3
Los Angeles 3
Abidjan 2
Bern 2
Boston 2
Hanoi 2
Ho Chi Minh City 2
Jakarta 2
Lappeenranta 2
Lauterbourg 2
Moscow 2
New York 2
Princeton 2
San Diego 2
San Jose 2
Allen Park 1
Andover 1
Bariri 1
Belford Roxo 1
Bremen 1
Brooklyn 1
Buffalo 1
Bình Tân 1
Canoas 1
Caxias do Sul 1
Chennai 1
Depok 1
Düsseldorf 1
Fairfield 1
Glenwood 1
Goianinha 1
Guarulhos 1
Haiphong 1
Islamabad 1
Itabuna 1
Kuala Lumpur 1
Lagoa da Prata 1
Lake View 1
Lancaster 1
London 1
Magé 1
Manchester 1
Marano Marchesato 1
Ottawa 1
Paraibuna 1
Phoenix 1
Portsmouth 1
Rabat 1
Resistencia 1
Reston 1
Revere 1
Riverside 1
Rome 1
San Luis 1
San Miguel 1
San Miguel de Tucumán 1
Santo Domingo de los Colorados 1
Siena 1
Simões Filho 1
Thanh Mỹ Tây 1
Tijuana 1
Toronto 1
Washington 1
Woodbridge 1
Yubileyny 1
Totale 223
Nome #
Efficacy and safety of a novel dosing strategy for ruxolitinib in the treatment of patients with myelofibrosis and anemia: the REALISE phase 2 study 164
Comparing the safety and efficacy of ruxolitinib in patients with Dynamic International Prognostic Scoring System low-, intermediate-1-, intermediate-2-, and high-risk myelofibrosis in JUMP, a Phase 3b, expanded-access study 133
Totale 297
Categoria #
all - tutte 884
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 884


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20228 0 0 0 0 0 0 0 4 0 0 0 4
2022/202335 3 10 0 2 2 7 4 2 3 0 0 2
2023/202411 0 2 3 0 2 2 0 0 0 2 0 0
2024/2025115 3 7 6 11 39 22 0 18 3 2 1 3
2025/2026120 9 13 11 8 17 7 11 8 7 5 9 15
2026/20278 8 0 0 0 0 0 0 0 0 0 0 0
Totale 297